Fosun relists ClubMed as standalone, but valuation may be hard
Fosun relists ClubMed as a standalone business about a year after privatising its tourism unit. TradingView News notes that matching valuations of faster-growing, more profitable hotel chains may be difficult.
By Ka Sing ChanJust a year after the conglomerate privatised its tourism unit that included the resort chain for $1.2 bln, it is now relisting ClubMed as a standalone business.
That's sensible.
But bagging a similar valuation as faster-growing, more profitable hotel chains will be tough.CONTEXT NEW…